| Access Family Care | |
|
1120 Carl Sweeney Rd Neosho MO 64850-7743 | |
| (417) 782-6200 | |
| (417) 782-6210 |
| Full Name | Access Family Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 1120 Carl Sweeney Rd, Neosho, Missouri |
| Authorized Official Name and Position | Donald Michael Mcbride (CEO) |
| Authorized Official Contact | 4174519450 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Access Family Care Po Box 758 Neosho MO 64850-0758 Ph: (417) 451-9450 | Access Family Care 1120 Carl Sweeney Rd Neosho MO 64850-7743 Ph: (417) 782-6200 |
| NPI Number | 1114626652 |
|---|---|
| Provider Enumeration Date | 02/23/2023 |
| Last Update Date | 08/10/2023 |
| Medicare PECOS PAC ID | 8123918257 |
|---|---|
| Medicare Enrollment ID | O20130619000166 |
News Archive
Watson Pharmaceuticals, Inc. has announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.
"In a study certain to rekindle debate over life-sustaining care for those with grievous brain injuries, researchers report that five patients thought to be in a persistent vegetative state showed brain activity indicating awareness, intent and, in at least one case, a wish to communicate," The Los Angeles Times reports.
In an important new study with implications for the treatment of dozens of incurable diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time created a drug candidate that attacks and neutralizes the RNA structure that causes an incurable progressive, inherited disease involving a gradual loss of control over body movement.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114626652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Watson Pharmaceuticals, Inc. has announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.
"In a study certain to rekindle debate over life-sustaining care for those with grievous brain injuries, researchers report that five patients thought to be in a persistent vegetative state showed brain activity indicating awareness, intent and, in at least one case, a wish to communicate," The Los Angeles Times reports.
In an important new study with implications for the treatment of dozens of incurable diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time created a drug candidate that attacks and neutralizes the RNA structure that causes an incurable progressive, inherited disease involving a gradual loss of control over body movement.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
› Verified 2 days ago
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2209 Oak Ridge Dr, Neosho, MO 64850 Phone: 417-451-0977 Fax: 417-451-7094 | |
Freeman Neosho Hospital Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 336 S Jefferson St, Neosho, MO 64850 Phone: 417-455-4200 | |
Freeman Neosho Physician Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 336 S Jefferson St, Neosho, MO 64850 Phone: 417-347-6605 | |
Free Market Physician Hospital Services, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4040 La Questa Dr, Neosho, MO 64850 Phone: 417-283-4953 | |
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1111 Wornall St, Neosho, MO 64850 Phone: 417-782-6200 Fax: 417-782-6210 | |
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 201 N Washington St, Neosho, MO 64850 Phone: 417-782-6200 Fax: 417-782-6210 |